The apparent proportion of column-chromatographically measured glycosylatedhemoglobinin erythrocytesfrom an indMdual with hemoglobins A, S, and G was only 2.3% because the slow glycosylated variant hemoglobins were retardedIn the column. In contrast,the value for glycosylated hemoglobinwas 7.8% by a new celluloseacetate electrophoretic methodthat includesuse of dextran sulfate buffer. Figure 1 ) was applied at the origin on the cellulose acetate strip usedfor electrophoretic determination ofglycosylated hemoglobin.The proportion of glycosylatedhemoglobin in five diabetic patients' samples was determined both by electrophoreticand chromatographic methods. The data were examined statistically.
Corp., Lexington Figure 1 ) was applied at the origin on the cellulose acetate strip usedfor electrophoretic determination ofglycosylated hemoglobin.The proportion of glycosylatedhemoglobin in five diabetic patients' samples was determined both by electrophoreticand chromatographic methods. The data were examined statistically.
Results
The mean cell volume was 83 fL; the hemoglobin concentration was 118 g/L of blood with 1+ microcytosis evident in the blood smear. The solubility test result was positive. The cellulose acetate electropherograin showedan "SAC" pattern, the citrate With use of this calculation the value for the glycosylated hemoglobin in our IThASG propositus is 5.75%, which corresponds poorly to the value of 7.8% we determined electrophoretically. However, the latter value was obtained several days after the colurnn-chromatographic value and it might reflect an increase during storage.
Recently we demonstrated (5) that an erytbrocyte metalloenzyme carbonic anhydrase B, co-migrates with HbF and glycosylated HbA on acid agar electrophoresis (pH 6.0-6.2).
Presumably, thissimilar mobilityis ascribedto the low affinity oftheseproteinsforthe negatively charged citrate ionsatacidpH. Because the electrophoretic method we used is based upon the affinity of non-glycosylated hemoglobin for negatively charged dextran sulfate, and HbF has a similar mobility to glycosylated hemoglobin in this acidic system, we thought carbonic anhydrase B might also co-migrate with glycosylated hemoglobin. Our experiment confirmed the presence of a single peak with less anodal mobilitythan HbA for carbonic anhydrase B. The similar electrophoretic mobility for both carbonic anhydrase B and glycosylated hemoglobin does not present a problem for use of citrate agar in glycosylated hemoglobin determination (6) because the electropherogram is scanned unstained at 420 nm, a wavelength at which carbonic anhydrase B has little absorbance (7). The lack of absorbance at 420 nm by carbonic anhydrase B also explains its failure to affect columnchromatographically measured glycosylated hemoglobin, because this protein co-elutes with the fast hemoglobin fraction and HbF at pH 6.7(7), owing to the low affinity of these proteinsfor the negatively charged weak cationexchanger Bio-Rex 70. Thus carbonic anhydrase B, HbF, and HbA1 all have low affinity for negative charges at acid pH. The electrophoretic method for glycosylated hemoglobin that we used involves the protein stain Ponceau S with densitometry at 525 nm to quantitate glycosylated hemoglobin, and carbonic anhydrase B probably contributed to the absorbance registered at this wavelength. Our densitometric analysis of a random hemolysate suggests carbonic anhydrase B composesabout 1.5% ofthetotal absorbanceat 525 nm and thus might contribute 15 to 20% of HbA1 absorbance within the normal range for HbA1 with the electrophoretic technique.Although our data and Janik's test evaluation data (2) suggest that carbonic anhydrase B doesnot falsely increase apparent HbA1 values, we believe interference would be significant when HbA1 proportions are in the low-normal range. Our samples from diabetics had a column-chromatographic mean of 10.7%, which is high,thus lessening the relative importance of carbonic anhydrase B, which should remain constant. Moreover, plotted data correlating thiselectrophoretic method with our coluinn-chromatographic method have a y intercept corresponding to 1.73% HbA1 (2), perhaps representing carbonic anhydrase B. Finally, carbonic anhydrase B may also have contributed to the higher than predicted electrophoretic HbA1 of our propositus' specimen.
Evidence such as the good correlation, the overlap of the normal range with existing methods, and the normal value for glycosylated hemoglobin in the presence of electrophoretically slow hemoglobin variants suggests that glycosylated hemoglobin can be determined by the electrophoretic technique that we used. Nevertheless, the microcolumnchromatographic determination of HbA1 is still the preferred method. The problem of contamination of glycosylated hemoglobin by fetal hemoglobin in ion-exchange chromatography should be solved by future developments in chromatographic glycosylated hemoglobin determinations in which affinity chromatography is used to measure the "true" proportion of glycosylated hemoglobin. We believe that carbonic anhydrase B contributes significantly to apparent glycosylated hemoglobin in the normal range as measured by electrophoresis involving the use of dextran sulfate. Subject-basedreferenceintervals(8) (a normal range based upon analyte variation in each individual) can be used to evaluate glycosylated hemoglobin in samples from individuals who are heterozygous for HbS or HbC, or the value for the glycosylated hemoglobin can be corrected according to Aleyassine's formula (4) when the columnchromatographic method is used. Electrophoretic determination of glycosylated hemoglobin should be reserved for patients without HbA-individuals with sickle-cell anemia, HbSC disease, or HbC homozygosity. Moreover, use of dextran sulfate electrophoresis to measure HbA1 in samples from these patients would be further limited by itsrequirement that the proportion of HbF be less than 1%.
